Alibaba and Payment Processor to Pay $600M Over Illegal Drug Sales
Auf einen Blick
- Alibaba and its US payment processor, AUS Merchant Services, will pay $600 million to resolve allegations of failing to prevent illegal drug sales on their platforms.
- The companies agreed to non-prosecution agreements, admitting to violations of the US Federal Food, Drug, and Cosmetic Act.
KI-generierte Zusammenfassung
Alibaba and its US payment processor, AUS Merchant Services, will pay $600 million to resolve allegations of failing to prevent illegal drug sales on their platforms. The companies agreed to non-prosecution agreements, admitting to violations of the US Federal Food, Drug, and Cosmetic Act.






